ArticleInternal medicine (Tokyo, Japan)2022

Prolonged COVID-19 in an Immunocompromised Patient Treated with Obinutuzumab and Bendamustine for Follicular Lymphoma.

Yayoi Ueda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.